Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone

NCT01626833 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Anorexia Nervosa
Interruption of Growth
Delayed Puberty
Osteopenia With Failure of Acquisition of Bone Mass

Interventions

DRUG: SOMATROPINE* : Norditropine® simplexx®
BIOLOGICAL: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]